Scleroderma natural history, complications and prognosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Scleroderma}} | {{Scleroderma}} | ||
{{CMG}} | |||
==Overview== | ==Overview== |
Revision as of 17:27, 13 June 2016
Scleroderma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Scleroderma natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Scleroderma natural history, complications and prognosis |
FDA on Scleroderma natural history, complications and prognosis |
CDC on Scleroderma natural history, complications and prognosis |
Scleroderma natural history, complications and prognosis in the news |
Blogs on Scleroderma natural history, complications and prognosis |
Risk calculators and risk factors for Scleroderma natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Natural History
Complications
Diffuse scleroderma can cause musculoskeletal, pulmonary, gastrointestinal, renal and other complications. Patients with larger amounts of cutaneous involvement are more likely to have involvement of the internal tissues and organs.
The most common cause of death in people with scleroderma is scarring of the lungs, called pulmonary fibrosis.
Other complications of scleroderma include:
- Cancer
- Heart failure
- High blood pressure in the lungs (pulmonary hypertension)
- Kidney failure
- Problems absorbing nutrients from food (malabsorption)
Prognosis
Some people with scleroderma have symptoms that develop quickly over the first few years and continue to get worse. However, in most patients, the disease slowly gets worse. People who only have skin symptoms have a better outlook. Widespread (systemic) scleroderma can damage the heart, kidney, lungs, or GI tract, which may cause death. Lung problems are the most common cause of death in patients with scleroderma.